Canopy Growth 4Q Loss Narrows, Revenue Rises

Dow Jones
06/15
 

By Adriano Marchese

 

Canopy Growth said its fourth-quarter loss narrowed as the company's Canadian cannabis business drove revenue growth and that it expects momentum to continue in the new fiscal year.

For the three months ended March 31, the Smiths Falls, Ontario cannabis company on Monday posted a narrowed net loss of 154.7 million Canadian dollars ($110.6 million), or C$0.40 a share, compared with a loss of C$196 million, or C$1.27 a share, in the comparable quarter a year ago.

Consolidated net revenue rose 10% to C$71.2 million, missing forecasts calling for growth to C$74.3 million.

The company's cannabis revenue rose 20% in the quarter to C$54.5 million, with Canadian medical cannabis sales rising 27% and adult-use cannabis increasing by 1%.

Meanwhile, the company's vaporizer manufacturing business, Storz & Bickel, saw revenue fall 14% to C$16.8 million.

Canopy Growth said that it expects net revenue to grow in fiscal 2027 as improved cultivation practices lift gross margins while cost-cutting measures reduce operating expenses.

The company also expects to achieve positive adjusted earnings before interest, taxes, depreciation and amortization in the year, with gains weighted toward the second half of the year.

 

Write to Adriano Marchese at adriano.marchese@wsj.com

 

(END) Dow Jones Newswires

June 15, 2026 07:37 ET (11:37 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10